NEW YORK (GenomeWeb) – The US Food and Drug Administration has issued an untitled letter to direct-to-consumer genetic testing firm DNA4Life requesting additional information on the company's recently launched Pharmacogenetic Report product.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.